Zoldonat Zoledronic Acid 4mg Injection

Get a Price/Quote

MOQ : 10 Pieces

Zoldonat Zoledronic Acid 4mg Injection Specification

Indication
Used for the treatment of osteoporosis, hypercalcemia of malignancy, Pagets disease, and prevention of skeletal-related events in cancer patients

Salt Composition
Zoledronic Acid 4mg

Dosage Form
Injection

Enzyme Types
Not applicable (Zoledronic Acid is not an enzyme)

Feature
Single dose vial, sterile, ready for intravenous use

Ingredients
Zoledronic Acid, suitable excipients, sterile water for injection

Application
Intravenous administration in clinical or hospital settings

Ph Level
Approximately 6.0 to 7.0 (typical injection pH range)

Physical Color/Texture
Clear, colorless solution

Storage Instructions
Store below 30C, protect from light, do not freeze

Shelf Life
24 months from date of manufacture

Usage
For use under medical supervision only

Prescription Status
Prescription only (Rx)

Packing
1 vial with solvent ampoule per box

Strength
4mg/5ml per vial

Country of Export
Available for export to Canada, EU, UK, USA, Australia (as illustrated)

Administration Route
Intravenous infusion

Zoldonat Zoledronic Acid 4mg Injection About

Zoldonat Zoledronic Acid 4mg Injection is a distinguished, best-seller medication, highly recommended by healthcare professionals for its optimum therapeutic efficacy. Each single-dose vial contains 4mg of Zoledronic Acid, designed for intravenous infusion under strict medical supervision. Noteworthy for its value and safety, Zoldonat is indicated for osteoporosis, hypercalcemia of malignancy, Paget's disease, and prevention of skeletal-related events in cancer patients. Manufactured in India, this sterile, ready-to-use solution is available for export to Canada, the EU, UK, USA, and Australia. Store below 30C and protect from light for a 24-month shelf life.

Distinguished Uses and Advantages of Zoldonat Injection

Zoldonat Zoledronic Acid 4mg Injection is predominantly used in the treatment of osteoporosis, hypercalcemia associated with malignancy, Paget's disease of bone, and for preventing skeletal complications in cancer patients. As a prescription-only medication, it is administered intravenously in clinical or hospital settings, ensuring optimum safety and efficacy. A key advantage lies in its clear, ready-to-use solution, providing convenience and reliable results under medical supervision.

Sample Policy and Delivery Process for Zoldonat

Zoldonat Injection's sample policy involves dispatching samples upon request at an agreed asking price, aligned with export procedures. The primary FOB port in India ensures seamless international delivery channels. After confirming your order, prompt dispatching is ensured, with delivery times varying based on destination - typically within a few days to a couple of weeks. Please contact us for further details regarding delivery arrangements and customized order requirements.

FAQ's of Zoldonat Zoledronic Acid 4mg Injection:

Q: How is Zoldonat Zoledronic Acid 4mg Injection administered?

A: Zoldonat Zoledronic Acid 4mg Injection should be administered only as an intravenous infusion by qualified medical personnel in a clinical or hospital setting.

Q: What are the main indications for using Zoldonat Injection?

A: Zoldonat is primarily prescribed for osteoporosis, hypercalcemia of malignancy, Paget's disease of bone, and to prevent skeletal complications in cancer patients.

Q: When should Zoldonat be used during treatment?

A: Zoldonat is used as directed by a healthcare provider, typically as part of a scheduled treatment plan for approved indications after careful patient assessment.

Q: Where can Zoldonat Zoledronic Acid 4mg Injection be exported?

A: Zoldonat is available for export to Canada, the European Union, United Kingdom, United States, and Australia, subject to regulatory compliance.

Q: What are the advantages of Zoldonat's single-dose vial?

A: The single-dose, ready-to-infuse sterile vial ensures convenience, accurate dosing, minimized contamination risk, and optimal patient safety during administration.